GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORABMUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY Best abstract submitted by a young investigator / travel grant recipient.
| Autor: | Tausch, E., Bahlo, J., Robrecht, S., Schneider, C., Bloehdorn, J., Schrell, S., Galler, C., Al‐Sawaf, O., Fink, A., Eichhorst, B., Kreuzer, K., Tandon, M., Humphrey, K., Jiang, Y., Schary, W., Porro Lurà, M., Döhner, H., Fischer, K., Hallek, M., Stilgenbauer, S. |
|---|---|
| Předmět: | |
| Zdroj: | Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p84-86, 3p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text